Predicting Post-Operative Pain and Analgesic Use: The Role of Endogenous Opioids
Predicting Post-Operative Pain and Analgesic Use: The Role of Endogenous Opioids
批准号:
8704403
负责人:
Claudia Michelle Campbell
金额:
$17.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2016-07-31
关键词:
AcuteAddressAffectAgeAmericanAnalgesicsArchitectureAwardClinicalClinical ResearchCohort StudiesDegenerative polyarthritisDevelopmentDoseDouble-Blind MethodEconomic BurdenEffectivenessEvaluationExhibitsFoundationsFundingGenetic Crossing OverGoalsHabitsHealthHealthcareIndividualIndividual DifferencesInterventionK-Series Research Career ProgramsKnee OsteoarthritisLaboratoriesLinkMediatingMentorsMentorshipMethodsModelingMonitorMoodsNaloxoneNeurobiologyOperative Surgical ProceduresOpioidOpioid AnalgesicsOutcomePainParentsPatient SchedulesPatientsPersistent painPharmaceutical PreparationsPhysical ExaminationPhysiciansPlacebo ControlPopulationPostoperative PainPostoperative PeriodPrevalenceProcessQuestionnairesResearchResearch InfrastructureResourcesRisk FactorsRoleSiteSleepSleep disturbancesSolidStudy modelsSymptomsSystemTestingTherapeutic InterventionThinkingTrainingWorkbasebiopsychosocialcentral painchronic paindesigndisabilityendogenous opioidsexperiencefollow-upfunctional disabilityhealth related quality of lifeimprovedknee painknee replacement arthroplastymodifiable riskneurobehavioralneurobiological mechanismparent grantpatient orientedpreventprogramsprospectivepsychosocialpublic health relevancetherapy design
中文摘要
描述(由申请人提供):此职业发展奖(K23)将为候选人提供必要的培训,以建立与了解关键神经行为风险因素(即,不规则的中枢疼痛处理、睡眠障碍和消极思维)影响神经生物学机制(即,内源性阿片样物质功能),导致疼痛结果的个体差异。慢性疼痛是影响相当大比例的美国人口的主要健康问题,并且与大量痛苦和经济负担相关。睡眠障碍、情绪和异常中枢疼痛处理已被确定为慢性疼痛和残疾的重要预测因子,并与内源性阿片功能受损间接相关。拟议的研究计划将系统地解决通过纳洛酮挑战对内源性阿片类药物功能进行直接术前测试的实用性,以预测膝关节骨关节炎(OA)患者全膝关节置换术(TKA)后的疼痛和阿片类镇痛药的使用,OA是最常见的慢性疼痛疾病之一,预计随着美国人口老龄化而急剧增加。该K23的具体培训目标包括指导,教学和经验,旨在发展疼痛,阿片类药物阻滞和睡眠评估方法的神经生物学专业知识,并在生物统计分析方面奠定坚实的基础。迄今为止,还没有研究检查异常中枢疼痛处理,睡眠障碍和情绪与内源性阿片功能受损之间的关系。因此,拟议的研究计划旨在调查这些风险因素是否共享神经生物学底物,将其与TKA后的重要临床疼痛结局联系起来,包括TKA后持续性疼痛和阿片类药物使用增加。特别是,拟定研究将系统评价通过纳洛酮激发进行的内源性阿片类药物功能的直接术前测试在预测TKA术后疼痛和阿片类药物使用方面的有效性。进一步的工作将研究内源性阿片功能是否与异常中枢疼痛处理,睡眠障碍,疼痛相关的负面思考疼痛。了解风险因素及其对TKA术后结局产生影响的潜在机制,将对手术患者的选择产生重要影响,为术后疼痛的管理提供信息,改善慢性疼痛患者的健康相关生活质量,并有助于制定旨在减少本提案中研究的风险因素影响的干预措施。候选人的长期目标是完善疼痛的生物心理社会模型,促进术后疼痛治疗干预的发展或加强,并预防慢性化。
英文摘要
DESCRIPTION (provided by applicant): This Career Development Award (K23) will provide the candidate the necessary training to establish a program of research related to understanding how key neurobehavioral risk factors (i.e., irregular central pain processing, sleep disturbance, and negative thinking) impact neurobiological mechanisms (i.e., endogenous opioid function) that contribute to individual differences in pain outcomes. Chronic pain is a major health problem affecting a significant proportion of the American population and is associated with substantial suffering and economic burden. Sleep disturbance, mood, and aberrant central pain processing have been identified as important predictors of chronic pain and disability, and have been indirectly associated with impaired endogenous opioid function. The proposed research plan will systematically address the utility of a direct pre-surgical test of endogenous opioid function via naloxone challenge in predicting pain and opioid analgesic use following total knee arthroplasty (TKA) in patients with knee osteoarthritis (OA), one of the most prevalent chronic pain conditions and predicted to drastically increase as the U.S. population ages. Specific training aims of this K23 include mentorship, didactics, and experiences designed to develop expertise in the neurobiology of pain, opioid blockade and sleep assessment methods as well as develop a solid foundation in biostatistical analyses. No research to date has examined the relationship between abnormal central pain processing, sleep disturbance, and mood with impaired endogenous opioid function. Consequently, the proposed research plan intends to investigate whether these risk factors share a neurobiological substrate that links them to important clinical pain outcomes following TKA, including persistent post-TKA pain, and increased opioid use. In particular, the proposed study will systematically evaluate the effectiveness of a direct pre- surgical test of endogenous opioid function via naloxone challenge in predicting post-operative pain and opioid use following TKA. Additional work will examine whether endogenous opioid function is associated with abnormal central pain processing, sleep disturbance, and pain related negative thinking on pain. Understanding the risk factors and underlying mechanisms whereby they exert their influence on outcomes following TKA, will have important implications for the selection of surgical patients, inform the management of post-operative pain, improve the health-related quality of life of individuals with chronic pain, and assist in the development of interventions designed to reduce the impact of the risk factors studied in this proposal. The candidate's long term goal is to refine biopsychosocial models of pain and facilitate the development or enhancement of therapeutic interventions for post-operative pain and to prevent chronicity.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Opioid-induced hyperalgesia: clinically relevant or extraneous research phenomenon?
阿片类药物引起的痛觉过敏:临床相关还是无关的研究现象?
DOI:
10.1007/s11916-010-0171-1
发表时间:
2011
期刊:
Current pain and headache reports
影响因子:
3.7
作者:
[Tompkins,DAndrew, Campbell,ClaudiaM]
通讯作者:
Campbell,ClaudiaM
DOI:
10.21767/2049-5471.1000116
发表时间:
2017-01-01
期刊:
Diversity and equality in health and care
影响因子:
--
作者:
[Burton, Emily F, Suen, Samuel Y, Campbell, Claudia M]
通讯作者:
Campbell, Claudia M
DOI:
10.1016/j.pain.2012.04.014
发表时间:
2012-09
期刊:
Pain
影响因子:
7.4
作者:
[Campbell CM, Kipnes MS, Stouch BC, Brady KL, Kelly M, Schmidt WK, Petersen KL, Rowbotham MC, Campbell JN]
通讯作者:
Campbell JN
DOI:
10.1002/ajmg.a.38051
发表时间:
2017-03
期刊:
American journal of medical genetics. Part A
影响因子:
--
作者:
[Speed TJ, Mathur VA, Hand M, Christensen B, Sponseller PD, Williams KA, Campbell CM]
通讯作者:
Campbell CM
Central Sensitization and Sleep Disturbance as Predictors of Treatment Outcomes in Patients with Knee Osteoarthritis
-
批准号:10456895
-
项目类别:
-
资助金额:$40.31万
-
财政年份:2021
-
负责人:Claudia Michelle Campbell
-
依托单位:
Central Sensitization and Sleep Disturbance as Predictors of Treatment Outcomes in Patients with Knee Osteoarthritis
-
批准号:10663903
-
项目类别:
-
资助金额:$41.03万
-
财政年份:2021
-
负责人:Claudia Michelle Campbell
-
依托单位:
Central Sensitization and Sleep Disturbance as Predictors of Treatment Outcomes in Patients with Knee Osteoarthritis
-
批准号:10306938
-
项目类别:
-
资助金额:$40.84万
-
财政年份:2021
-
负责人:Claudia Michelle Campbell
-
依托单位:
Mentorship of Junior Investigators on HEAL-SKOAP
-
批准号:10426755
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2021
-
负责人:Claudia Michelle Campbell
-
依托单位:
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
-
批准号:10352674
-
项目类别:
-
资助金额:$15.56万
-
财政年份:2019
-
负责人:Claudia Michelle Campbell
-
依托单位:
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
-
批准号:10700013
-
项目类别:
-
资助金额:$116.41万
-
财政年份:2019
-
负责人:Claudia Michelle Campbell
-
依托单位:
Increasing Participant Diversity in a 'Sequenced-Strategy to Improve Outcomes in people with Knee Osteoarthritis Pain (SKOAP)
-
批准号:10400316
-
项目类别:
-
资助金额:$52.38万
-
财政年份:2019
-
负责人:Claudia Michelle Campbell
-
依托单位:
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
-
批准号:10271400
-
项目类别:
-
资助金额:$538.21万
-
财政年份:2019
-
负责人:Claudia Michelle Campbell
-
依托单位:
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
-
批准号:10258492
-
项目类别:
-
资助金额:$335.35万
-
财政年份:2019
-
负责人:Claudia Michelle Campbell
-
依托单位:
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
-
批准号:10917533
-
项目类别:
-
资助金额:$15.56万
-
财政年份:2019
-
负责人:Claudia Michelle Campbell
-
依托单位:
Opioid and cannabinoid combinations in laboratory and clinical pain
-
批准号:9479123
-
项目类别:
-
资助金额:$75.23万
-
财政年份:2017
-
负责人:Claudia Michelle Campbell
-
依托单位:
Opioid and cannabinoid combinations in laboratory and clinical pain
-
批准号:9686723
-
项目类别:
-
资助金额:$74.74万
-
财政年份:2017
-
负责人:Claudia Michelle Campbell
-
依托单位:
Opioid and cannabinoid combinations in laboratory and clinical pain
-
批准号:9218182
-
项目类别:
-
资助金额:$74.95万
-
财政年份:2017
-
负责人:Claudia Michelle Campbell
-
依托单位:
Using Cannabinoids to Enhance Opioid Analgesic Effects in Humans
-
批准号:9502262
-
项目类别:
-
资助金额:$69.4万
-
财政年份:2016
-
负责人:Claudia Michelle Campbell
-
依托单位:
Using Cannabinoids to Enhance Opioid Analgesic Effects in Humans
-
批准号:9173259
-
项目类别:
-
资助金额:$68.22万
-
财政年份:2016
-
负责人:Claudia Michelle Campbell
-
依托单位:
Using Cannabinoids to Enhance Opioid Analgesic Effects in Humans
-
批准号:9962328
-
项目类别:
-
资助金额:$65.71万
-
财政年份:2016
-
负责人:Claudia Michelle Campbell
-
依托单位:
Ethnic differences in endogenous pain regulation: PET imaging of opioid receptors
-
批准号:8775467
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2014
-
负责人:Claudia Michelle Campbell
-
依托单位:
Predicting Post-Operative Pain and Analgesic Use: The Role of Endogenous Opioids
-
批准号:7952869
-
项目类别:
-
资助金额:$17.61万
-
财政年份:2010
-
负责人:Claudia Michelle Campbell
-
依托单位:
Predicting Post-Operative Pain and Analgesic Use: The Role of Endogenous Opioids
-
批准号:8138369
-
项目类别:
-
资助金额:$17.61万
-
财政年份:2010
-
负责人:Claudia Michelle Campbell
-
依托单位:
Predicting Post-Operative Pain and Analgesic Use: The Role of Endogenous Opioids
-
批准号:8545241
-
项目类别:
-
资助金额:$17.61万
-
财政年份:2010
-
负责人:Claudia Michelle Campbell
-
依托单位:
海外基金